StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

LBRXBullishAnalyst Target Updateanalyst
High materiality8/10

LB Pharmaceuticals price target raised to $60 from $45 at HC Wainwright

Aug 25, 2026, 12:01 AM EDT1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

bullish

AI summary

What happened, with direct paths to the underlying reporting

HC Wainwright raises LBRX target to $60; current price $47.62; upside ~26%; priceChangeSinceSignal +1.24.

  • Target $60; Price $47.62; Upside ~26%; Change +1.24.

Key facts

  1. 01

    Target: $60

  2. 02

    Posted price: $47.62

  3. 03

    Analyst firm: H.C. Wainwright

  4. 04

    Analyst: Raghuram Selvaraju

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.